.

Mirati Therapeutics reported $-176445000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Agios Pharmaceuticals AGIO:US $ -91.81M 2.97M
Alnylam Pharmaceuticals ALNY:US $ -277.4M 37.06M
Amgen AMGN:US $ 1317M 159M
Astellas Pharma 4503:JP Y 24812M 33220M
AstraZeneca AZN:LN 29568.96M 177.38M
Bayer BAYN:GR € -298M 3589M
Biocryst Pharmaceuticals BCRX:US $ -58.86M 15.34M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Bristol Myers Squibb BMY:US $ 1421M 143M
Eisai 4523:JP Y 26898M 39301M
Eli Lilly And LLY:US $ 952.5M 950.4M
Exelixis EXEL:US $ 70.67M 2.1M
Gilead Sciences GILD:US $ 1144M 1125M
GlaxoSmithKline GSK:LN 83800M 96400M
IONIS PHARMACEUT IONS:US $ -105.14M 39.97M
Johnson & Johnson JNJ:US $ 4814M 335M
Merk MRK:US $ 3944M 366M
Moderna Inc MRNA:US 2.2B 1.46B
Nektar Therapeutics NKTR:US $ -159.07M 68.68M
Novartis NOVN:VX SF 1694M 528M
Pfizer PFE:US $ 9905M 2042M
Puma Biotechnology PBYI:US $ 9.37M 12.77M
Sarepta Therapeutics SRPT:US $ -231.48M 126.46M
Seattle Genetics SGEN:US $ -134.83M 1.67M
Spectrum Pharmaceuticals SPPI:US $ -29.05M 13.61M
Takeda 4502:JP Y 105014M 116372M
Ultragenyx Pharmaceutical RARE:US $ -158.16M 5.84M
YTE INCY:US $ 161.43M 123.44M